Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Pacific Biosciences of California (PACB) stock

Learn how to easily invest in Pacific Biosciences of California stock.

Pacific Biosciences of California, Inc
NASDAQ: PACB - USD
DIAGNOSTICS & RESEARCH
$30.36
-$1.00 (-3.17%)

Pacific Biosciences of California, Inc is a diagnostics & research business based in the US. Pacific Biosciences of California shares (PACB) are listed on the NASDAQ and all prices are listed in US Dollars. Pacific Biosciences of California employs 412 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Pacific Biosciences of California

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PACB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Pacific Biosciences of California stock price (NASDAQ: PACB)

Use our graph to track the performance of PACB stocks over time.

Pacific Biosciences of California shares at a glance

Information last updated 2021-07-23.
Latest market close$27.05
52-week range$3.57 - $53.69
50-day moving average $30.33
200-day moving average $31.84
Wall St. target price$47.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.17

Buy Pacific Biosciences of California shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Pacific Biosciences of California stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pacific Biosciences of California price performance over time

Historical closes compared with the close of $27.05 from 2021-05-28

1 week (2021-07-12) N/A
1 month (2021-06-23) -13.85%
3 months (2021-04-19) N/A
6 months (2021-01-19) N/A
1 year (2020-07-19) N/A
2 years (2019-07-19) N/A
3 years (2018-07-19) N/A
5 years (2016-07-19) N/A

Pacific Biosciences of California financials

Revenue TTM $92.3 million
Gross profit TTM $32.6 million
Return on assets TTM -8.85%
Return on equity TTM -34.78%
Profit margin -64.25%
Book value $1.42
Market capitalisation $6.2 billion

TTM: trailing 12 months

Shorting Pacific Biosciences of California shares

There are currently 13.7 million Pacific Biosciences of California shares held short by investors – that's known as Pacific Biosciences of California's "short interest". This figure is 0.9% down from 13.8 million last month.

There are a few different ways that this level of interest in shorting Pacific Biosciences of California shares can be evaluated.

Pacific Biosciences of California's "short interest ratio" (SIR)

Pacific Biosciences of California's "short interest ratio" (SIR) is the quantity of Pacific Biosciences of California shares currently shorted divided by the average quantity of Pacific Biosciences of California shares traded daily (recently around 2.1 million). Pacific Biosciences of California's SIR currently stands at 6.45. In other words for every 100,000 Pacific Biosciences of California shares traded daily on the market, roughly 6450 shares are currently held short.

However Pacific Biosciences of California's short interest can also be evaluated against the total number of Pacific Biosciences of California shares, or, against the total number of tradable Pacific Biosciences of California shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pacific Biosciences of California's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Pacific Biosciences of California shares in existence, roughly 70 shares are currently held short) or 0.0731% of the tradable shares (for every 100,000 tradable Pacific Biosciences of California shares, roughly 73 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Pacific Biosciences of California.

Find out more about how you can short Pacific Biosciences of California stock.

Pacific Biosciences of California share dividends

We're not expecting Pacific Biosciences of California to pay a dividend over the next 12 months.

Pacific Biosciences of California share price volatility

Over the last 12 months, Pacific Biosciences of California's shares have ranged in value from as little as $3.57 up to $53.69. A popular way to gauge a stock's volatility is its "beta".

PACB.US volatility(beta: 1.12)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pacific Biosciences of California's is 1.1186. This would suggest that Pacific Biosciences of California's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Pacific Biosciences of California overview

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc.

Frequently asked questions

What percentage of Pacific Biosciences of California is owned by insiders or institutions?
Currently 6.796% of Pacific Biosciences of California shares are held by insiders and 89.275% by institutions.
How many people work for Pacific Biosciences of California?
Latest data suggests 412 work at Pacific Biosciences of California.
When does the fiscal year end for Pacific Biosciences of California?
Pacific Biosciences of California's fiscal year ends in December.
Where is Pacific Biosciences of California based?
Pacific Biosciences of California's address is: 1305 O?Brien Drive, Menlo Park, CA, United States, 94025
What is Pacific Biosciences of California's ISIN number?
Pacific Biosciences of California's international securities identification number is: US69404D1081
What is Pacific Biosciences of California's CUSIP number?
Pacific Biosciences of California's Committee on Uniform Securities Identification Procedures number is: 69404D108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site